Status: current, Defined. Date: 30-Apr 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4555181000168114 | Cabenuva Cabotegravir (cabotegravir 400 mg / 2 mL) modified release injection, 2 mL vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4555191000168112 | Cabenuva Cabotegravir 400 mg/2 mL modified release injection, 2 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Cabenuva Cabotegravir 400 mg/2 mL modified release injection, 2 mL vial | Is a | Cabenuva Cabotegravir | true | Inferred relationship | Some | ||
| Cabenuva Cabotegravir 400 mg/2 mL modified release injection, 2 mL vial | Is a | cabotegravir 400 mg/2 mL modified release injection, vial | true | Inferred relationship | Some | ||
| Cabenuva Cabotegravir 400 mg/2 mL modified release injection, 2 mL vial | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Cabenuva Cabotegravir 400 mg/2 mL modified release injection, 2 mL vial | has manufactured dose form | modified release injection | true | Inferred relationship | Some | ||
| Cabenuva Cabotegravir 400 mg/2 mL modified release injection, 2 mL vial | has unit of use | vial | true | Inferred relationship | Some | 424931977 | |
| Cabenuva Cabotegravir 400 mg/2 mL modified release injection, 2 mL vial | has intended active ingredient | cabotegravir | true | Inferred relationship | Some | 1760701123 | |
| Cabenuva Cabotegravir 400 mg/2 mL modified release injection, 2 mL vial | has Australian BoSS | cabotegravir | true | Inferred relationship | Some | 1760701123 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Cabenuva Cabotegravir 400 mg/2 mL modified release injection, 2 mL vial | has TPUU | True | Cabenuva Cabotegravir 400 mg/2 mL modified release injection, 2 mL vial | Inferred relationship | Some | 1060597706 |
| Cabenuva Cabotegravir 400 mg/2 mL modified release injection, 2 mL vial | has TPUU | True | Cabenuva Cabotegravir 400 mg/2 mL modified release injection, 2 mL vial | Inferred relationship | Some | 235968883 |
| Cabenuva (1 x Cabotegravir 400 mg/2 mL vial, 1 x Rilpivirine 600 mg/2 mL vial), 1 pack | has TPUU | True | Cabenuva Cabotegravir 400 mg/2 mL modified release injection, 2 mL vial | Inferred relationship | Some | 104958920 |
| Cabenuva (1 x Cabotegravir 400 mg/2 mL vial, 1 x Rilpivirine 600 mg/2 mL vial), 1 pack | has TPUU | True | Cabenuva Cabotegravir 400 mg/2 mL modified release injection, 2 mL vial | Inferred relationship | Some | 1720136335 |
Reference Sets
Black Triangle Scheme reference set
Trade product unit of use reference set